A Preliminary Pilot Study on the Co-petition of the Pharmaceutical Industry through Analyzing the Situation of Taiwan and China

• Main Authors: Ming-Huei Liang, 梁明暉
• Other Authors: 王銘宗
• Format: Others
• Language: zh-TW
• Published: 2002
• Online Access: http://ndltd.ncl.edu.tw/handle/59294536222028835053

碩士 === 國立臺灣大學 === 工業工程學研究所 === 90 === As the recent trend, it is the era of information and telecommunication, but the biotech industry is in bud with little noise, we know that people in any place from ancient to date need the medical industry, and recently it is combined with biotech, there is much advance breakthrough. And the authorities of Mainland China carry out reformation, is opening up more and more and closer with Taiwan daily. There is more than competition; there is more chance of cooperation to cross-Strait. The above mentioned subjects are more and more important to nowadays, and the relative researches are also beyond our imagine, but few merge the said into a single whole, so the research is expected to accomplish the ideal. So the research is based on the two trends as the characterization of the front two phases, use ‘A Preliminary Pilot Study on the Co-petition of the Pharmaceutical Industry through Analyzing the Situation of Taiwan and China’ as the title of the research. As the first step, finding out the definition of pharmaceutical industry and compare the chemical pharmaceutical industry with biotech one by collecting related literatures； and then we will discuss the structure of this industry, and research on the present situation and trend of pharmaceutical industry from research and development through manufacturing to marketing. Then, discussing the definition and related theories of co-petition and the model of the global pharmaceutical industry, and prove by the related cases. And discussing the present situation of the pharmaceutical industry of cross-Strait in depth, and research the PEST/SWOT analysis of them. Then we will research their supply chain, and discuss how the pharmaceutical industry of cross-Strait co-petite with other zones, interact with the government machinery, science and research units, and learn the advantages of the tech advanced countries through benchmarking. Last but not the least, collecting the interview of the experts from the industry, related juridical persons and government machineries, and integrating their points of view. From the subjects of the industry, the related policy, and the interaction with the factories of the Mainland China prove the interview and the research content. Though there is the limitation of laggard and low-reality data about Mainland China exists, the trend of the cross-Strait is so important to the research, so it is necessary to find the representative authoritative data such as the China Medicine Administration, to integrate the content of research, and bring up suggestions to the relative government machines and the firms, and to open a road to the following researches.